Future large-scale cohort studies assessing mucin production, particularly MUC2 and MUC5AC expression, alongside genetic mutations associated with CRC development, could provide a clearer understanding of the relationships between nMAC, MCP, and MAC [4]. This evidence concerns the gene MUC2 and colorectal carcinoma.